BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23716537)

  • 1. CD30 expression in peripheral T-cell lymphomas.
    Sabattini E; Pizzi M; Tabanelli V; Baldin P; Sacchetti CS; Agostinelli C; Zinzani PL; Pileri SA
    Haematologica; 2013 Aug; 98(8):e81-2. PubMed ID: 23716537
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
    Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
    Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.
    Bisig B; de Reyniès A; Bonnet C; Sujobert P; Rickman DS; Marafioti T; Delsol G; Lamant L; Gaulard P; de Leval L
    Haematologica; 2013 Aug; 98(8):1250-8. PubMed ID: 23716562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.
    de Leval L; Rickman DS; Thielen C; Reynies Ad; Huang YL; Delsol G; Lamant L; Leroy K; Brière J; Molina T; Berger F; Gisselbrecht C; Xerri L; Gaulard P
    Blood; 2007 Jun; 109(11):4952-63. PubMed ID: 17284527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels.
    Bossard C; Dobay MP; Parrens M; Lamant L; Missiaglia E; Haioun C; Martin A; Fabiani B; Delarue R; Tournilhac O; Delorenzi M; Gaulard P; de Leval L
    Blood; 2014 Nov; 124(19):2983-6. PubMed ID: 25224410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCL-6 protein expression in human peripheral T-cell neoplasms is restricted to CD30+ anaplastic large-cell lymphomas.
    Carbone A; Gloghini A; Gaidano G; Dalla-Favera R; Falini B
    Blood; 1997 Sep; 90(6):2445-50. PubMed ID: 9310496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral T-cell lymphomas expressing CD30 and CD15.
    Barry TS; Jaffe ES; Sorbara L; Raffeld M; Pittaluga S
    Am J Surg Pathol; 2003 Dec; 27(12):1513-22. PubMed ID: 14657710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent expression of CD30 in extranodal NK/T-cell lymphoma: Potential therapeutic target for anti-CD30 antibody-based therapy.
    Kawamoto K; Miyoshi H; Suzuki T; Sasaki Y; Yamada K; Yanagida E; Muto R; Kiryu M; Sone H; Seto M; Ohshima K; Takizawa J
    Hematol Oncol; 2018 Feb; 36(1):166-173. PubMed ID: 29052238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral T cell and natural killer (NK) T cell lymphomas: a clinicopathological study from a single Australian centre.
    McKelvie PA; Thompson PA; Tam CS
    Histopathology; 2012 Aug; 61(2):212-23. PubMed ID: 22716228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomas.
    Uemura Y; Isobe Y; Uchida A; Asano J; Nishio Y; Sakai H; Hoshikawa M; Takagi M; Nakamura N; Miura I
    Cancer Sci; 2018 Apr; 109(4):1254-1262. PubMed ID: 29363227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the role of Epstein-Barr virus in cases of nodal or extranodal T- and NK-cell lymphoma using eber in situ hybridization.
    Karaarslan S; Hekimgil M; Soydan S; Ertan Y; Doğanavşargil B
    Pol J Pathol; 2015 Jun; 66(2):161-9. PubMed ID: 26247530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20.
    Song JY; Strom T; Raffeld M; Pittaluga S; Jaffe ES
    J Clin Oncol; 2011 Nov; 29(32):e789-91. PubMed ID: 21990402
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis of mature T-cell and NK-cell lymphoma with CD30 expression based on latest WHO classification].
    Feng Y; Fu J; Yan S; Ling Y; Huang Y; Cai M; Rao H
    Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):508-11. PubMed ID: 25346118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities.
    Kim WY; Nam SJ; Kim S; Kim TM; Heo DS; Kim CW; Jeon YK
    Leuk Lymphoma; 2015 Jun; 56(6):1778-86. PubMed ID: 25288491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD30 expression in cutaneous B-cell and post-transplant peripheral T-cell lymphoma: report of 2 cases.
    Albrecht H; Woodroof JM; Reyes R; Powers BC; Fraga GR
    Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of microRNA in ALK-negative anaplastic large cell lymphoma and CD30-positive peripheral T cell lymphoma, not otherwise specified].
    Wang C; Chen X; Chen X; He Y; Cao L
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):565-70. PubMed ID: 26705180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD30 expression in extranodal natural killer/T-cell lymphoma, nasal type among 622 cases of mature T-cell and natural killer-cell lymphoma at a single institution in South China.
    Feng Y; Rao H; Lei Y; Huang Y; Wang F; Zhang Y; Xi S; Wu Q; Shao J
    Chin J Cancer; 2017 May; 36(1):43. PubMed ID: 28486951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
    Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
    J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.
    Boddicker RL; Kip NS; Xing X; Zeng Y; Yang ZZ; Lee JH; Almada LL; Elsawa SF; Knudson RA; Law ME; Ketterling RP; Cunningham JM; Wu Y; Maurer MJ; O'Byrne MM; Cerhan JR; Slager SL; Link BK; Porcher JC; Grote DM; Jelinek DF; Dogan A; Ansell SM; Fernandez-Zapico ME; Feldman AL
    Blood; 2015 May; 125(20):3118-27. PubMed ID: 25833963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and αβ, γδ, and αβ/γδ T-cell origin: a comprehensive clinicopathologic and phenotypic study.
    Pongpruttipan T; Sukpanichnant S; Assanasen T; Wannakrairot P; Boonsakan P; Kanoksil W; Kayasut K; Mitarnun W; Khuhapinant A; Bunworasate U; Puavilai T; Bedavanija A; Garcia-Herrera A; Campo E; Cook JR; Choi J; Swerdlow SH
    Am J Surg Pathol; 2012 Apr; 36(4):481-99. PubMed ID: 22314189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.